{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:16:24Z","timestamp":1788408984525,"version":"build-2803163510"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1985,10,1]],"date-time":"1985-10-01T00:00:00Z","timestamp":496972800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmacokinetics and Biopharmaceutics"],"published-print":{"date-parts":[[1985,10]]},"DOI":"10.1007\/bf01059331","type":"journal-article","created":{"date-parts":[[2005,1,28]],"date-time":"2005-01-28T13:56:42Z","timestamp":1106920602000},"page":"477-492","source":"Crossref","is-referenced-by-count":74,"title":["Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats"],"prefix":"10.1007","volume":"13","author":[{"given":"Yasufumi","family":"Sawada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Hanano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuji","family":"Iga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[1985,10,1]]},"reference":[{"key":"BF01059331_CR1","first-page":"136","volume":"13","author":"L. B. Mellett","year":"1969","unstructured":"L. B. Mellett. Comparative drug metabolism.Prog. Drug Res,13:136\u2013169 (1969).","journal-title":"Prog. Drug Res"},{"key":"BF01059331_CR2","first-page":"95","volume":"54","author":"R. L. Dedrick","year":"1970","unstructured":"R. L. Dedrick, K. B. Bischoff, and D. S. Zaharko. Interspecies correlation of plasma concentration history of methotrexate.Cancer Chemother. Part 1 54:95\u2013101 (1970).","journal-title":"Cancer Chemother. Part 1"},{"key":"BF01059331_CR3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/BF01059667","volume":"1","author":"R. L. Dedrick","year":"1973","unstructured":"R. L. Dedrick. Animal scale up.J. Pharmacokin. Biopharm. 1:435\u2013461 (1973).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"BF01059331_CR4","first-page":"67","volume":"199","author":"U. Klotz","year":"1976","unstructured":"U. Klotz, K. H. Antonin, and P. R. Bieck. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig, and rat.J. Pharmacol. Exp. Ther. 199:67\u201373 (1976).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF01059331_CR5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/03602537808993770","volume":"7","author":"C. H. Walker","year":"1978","unstructured":"C. H. Walker. Species differences in microsomal monoxygenase activity and their relationship to biological half-lives.Drug Metab. Rev. 7:295\u2013323 (1978).","journal-title":"Drug Metab. Rev."},{"key":"BF01059331_CR6","first-page":"113","volume-title":"Progress in Drug Metabolism, Vol. 5","author":"C. H. Walker","year":"1980","unstructured":"C. H. Walker. Species variations in some hepatic microsomal enzymes that metabolize xenobiotics. In: J. W. Bridges and L. F. Chasseaud (eds.),Progress in Drug Metabolism, Vol. 5, Wiley, London, 1980, Chapter 2, pp. 113\u2013164."},{"key":"BF01059331_CR7","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/0006-2952(73)90342-0","volume":"22","author":"R. L. Dedrick","year":"1973","unstructured":"R. L. Dedrick, D. D. Forester, J. N. Cannon, S. M. E. Dareen, and L. B. Mellett. Pharmacokinetics of 1-\u03b2-spd-arabino-furanosylcytosine (Ara-C) deamination in several species.Biochem. Pharmacol. 22:2405\u20132417 (1973).","journal-title":"Biochem. Pharmacol."},{"key":"BF01059331_CR8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01065191","volume":"8","author":"H. Boxenbaum","year":"1980","unstructured":"H. Boxenbaum. Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance Extrapolation of data to benzodiazepines and phenytoin.J. Pharmacokin. Biopharm. 8:165\u2013176 (1980).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"BF01059331_CR9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF01062336","volume":"10","author":"H. Boxenbaum","year":"1982","unstructured":"H. Boxenbaum. Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics.J. Pharmacokin. Biopharm. 10:201\u2013227 (1982).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"BF01059331_CR10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF01065172","volume":"10","author":"H. Boxenbaum","year":"1982","unstructured":"H. Boxenbaum. Comparative pharmacokinetics of benzodiazepines in dog and man.J. Pharmacokin. Biopharm. 10:411\u2013426 (1982).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"BF01059331_CR11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF01061720","volume":"12","author":"Y. Sawada","year":"1984","unstructured":"Y. Sawada, M. Hanano, Y. Sugiyama, and T. Iga. Prediction of the disposition of\u03b2-lactum antibiotics in human from pharmacokinetic parameters in animals.J. Pharmacokin. Biopharm. 12:241\u2013261 (1984).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"BF01059331_CR12","first-page":"699","volume-title":"The Pharmacological Basis of Therapeutics","author":"L. Z. Benet","year":"1980","unstructured":"L. Z. Benet and L. B. Sheiner. Design and optimization of dosage regimens; Pharmacokinetic data. In L. S. Goodman and A. Gilman (eds.),The Pharmacological Basis of Therapeutics, 6th ed. Macmillan, New York, 1980, pp. 699, 1737.","edition":"6th ed."},{"key":"BF01059331_CR13","first-page":"583","volume":"211","author":"R. G. Dickison","year":"1979","unstructured":"R. G. Dickison, R. C. Harland, A. M. Ilias, R. M. Rodgers, S. N. Kaufman, R. K. Lynn, and N. Gerber. Disposition of valproic acid in the rat: Dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect.J. Pharmacol. Exp. Ther. 211:583\u2013595 (1979).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF01059331_CR14","unstructured":"Y. Tanimura. Pharmacokinetics of Phenylbutazone and Its Metabolites in Rats. Ph.D. thesis, University of Tokyo (1979)."},{"key":"BF01059331_CR15","first-page":"69","volume":"3","author":"T. Inaba","year":"1975","unstructured":"T. Inaba and T. Umeda. Biliary excretion of diphenylhydantoin in the rat.Drug Metab. Dispos. 3:69\u201373 (1975).","journal-title":"Drug Metab. Dispos."},{"key":"BF01059331_CR16","first-page":"429","volume":"2","author":"T. Inaba","year":"1974","unstructured":"T. Inaba, E. Tsutsumi, W. A. Mahon, and W. Kalow. Biliary excretion of diazepam in the rat.Drug Metab. Dispos. 2:429\u2013432 (1974).","journal-title":"Drug Metab. Dispos."},{"key":"BF01059331_CR17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0378-5173(83)90165-5","volume":"15","author":"F. Ichimura","year":"1983","unstructured":"F. Ichimura, K. Yokogawa, T. Yamana, A. Tsuji, and Y. Mizukami. Physiological pharmacokinetic model for pentazoxine. I. Tissue distribution and elimination in the rat.Int. J. Pharm. 15:321\u2013333 (1983).","journal-title":"Int. J. Pharm."},{"key":"BF01059331_CR18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF01059688","volume":"5","author":"K. S. Pang","year":"1977","unstructured":"K. S. Pang and M. Rowland. Hepatic clearance of drugs. I. Theoretical considerations of a \u201cwell-stirred\u201d model and a \u201cparallel tube\u201d model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzyme activity on hepatic drug clearance.J. Pharmacokin. Biopharm. 5:625\u2013653 (1977).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"BF01059331_CR19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/cpt1975184377","volume":"18","author":"G. R. Wilkinson","year":"1975","unstructured":"G. R. Wilkinson and D. G. Shand. A physiological approach to hepatic drug clearance.Clin. Pharmacol. Ther. 18:377\u2013390 (1975).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF01059331_CR20","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/jps.2600730513","volume":"73","author":"O. Sugita","year":"1984","unstructured":"O. Sugita, Y. Sawada, Y. Sugiyama, T. Iga, and M. Hanano. Effect of sulphaphenazole on tolbutamide distribution in rabbits. Analysis of interspecies difference in tissue distribution of tolbutamide.J. Pharm. Sci. 73:631\u2013634 (1984).","journal-title":"J. Pharm. Sci."},{"key":"BF01059331_CR21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0300-9629(80)90255-8","volume":"67A","author":"J. W. Prothero","year":"1980","unstructured":"J. W. Prothero. Scaling of blood parameters in mammals.Comp. Biochem. Physiol. 67A:649\u2013657 (1980).","journal-title":"Comp. Biochem. Physiol."},{"key":"BF01059331_CR22","first-page":"17","volume":"33","author":"U. K. Hansen","year":"1981","unstructured":"U. K. Hansen. Molecular aspect of ligand binding to serum albumin.Pharmacol. Rev. 33: 17\u201353 (1981).","journal-title":"Pharmacol. Rev."},{"key":"BF01059331_CR23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2165\/00003088-198005030-00004","volume":"5","author":"K. M. Piafsky","year":"1980","unstructured":"K. M. Piafsky. Disease-induced changes in the plasma binding of basic drugs.Clin. Pharmacokin. 5:246\u2013262 (1980).","journal-title":"Clin. Pharmacokin."},{"key":"BF01059331_CR24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/clpt.1981.34","volume":"29","author":"M. K. Romach","year":"1981","unstructured":"M. K. Romach, K. M. Piafsky, J. G. Abel, V. Khouw, and E. M. Sellers. Methasone binding to orosomucoid (\u03b1 1-acid glycoprotein): Determinant of free fraction in plasma.Clin. Pharmacol. Ther. 29:211\u2013217 (1981).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF01059331_CR25","first-page":"187","volume":"17","author":"S. Glasson","year":"1980","unstructured":"S. Glasson, R. Zili, P. D. Athis, J. P. Tillement, and J. R. Boissier. The distribution of bound propranolol between the different human serum proteins.Mol. Pharmacol. 17:187\u2013191 (1980).","journal-title":"Mol. Pharmacol."},{"key":"BF01059331_CR26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF00512392","volume":"322","author":"W. E. Muller","year":"1983","unstructured":"W. E. Muller and A. E. Stillbaluer. Characterization of a common binding site for basic drugs on human\u03b1 1-acid glycoprotein (orosomucoid).Naunyn-Schmiedeberg's Arch. Pharmacol. 322:170\u2013173 (1983).","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"BF01059331_CR27","first-page":"741","volume":"219","author":"J. J. Lima","year":"1981","unstructured":"J. J. Lima, H. Boudoulas, and M. Blanford. Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics.J. Pharmacol. Exp. Ther. 219:741\u2013747 (1981).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF01059331_CR28","first-page":"1007","volume":"25","author":"O. G. Nilsin","year":"1976","unstructured":"O. G. Nilsin. Serum albumin and lipoproteins as the quinidine binding molecules in normal human sera. Biochem.Pharmacol. 25:1007\u20131012 (1976).","journal-title":"Pharmacol."},{"key":"BF01059331_CR29","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/jps.2600641015","volume":"64","author":"A. Yacobi","year":"1975","unstructured":"A. Yacobi and G. Levy. Comparative pharmacokinetics of coumarin and anticoagulants XIV: Relationship between protein binding distribution and elimination kinetics of warfarin in rats.J. Pharm. Sci. 64:1660\u20131664 (1975).","journal-title":"J. Pharm. Sci."},{"key":"BF01059331_CR30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/cpt1976195part1552","volume":"19","author":"A. Yacobi","year":"1976","unstructured":"A. Yacobi, J. A. Udall, and G. Levy. Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect.Clin. Pharmacol. Ther. 19:552\u2013558 (1976).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF01059331_CR31","first-page":"114","volume":"186","author":"G. H. Evans","year":"1973","unstructured":"G. H. Evans, A. S. Nies, and D. G. Shand. The disposition of propanolol. III. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.J. Pharmacol. Exp. Ther. 186:114\u2013122 (1973).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF01059331_CR32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00563104","volume":"15","author":"D. Fremstad","year":"1979","unstructured":"D. Fremstad, O. G. Nilsen, L. Storstein, J. Amlie, and S. Jacobsen. Pharmacokinetics of quinidine related to plasma protein binding in man.Eur. J. Clin. Pharmacol. 15:187\u2013192 (1979).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BF01059331_CR33","first-page":"500","volume":"203","author":"W. A. Colburn","year":"1977","unstructured":"W. A. Colburn and M. Gibaldi. Plasma protein binding and metabolic clearance of phenytoin in the rat.J. Pharmacol. Exp. Ther. 203:500\u2013506 (1977).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF01059331_CR34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/BF01059058","volume":"11","author":"Y. Igari","year":"1983","unstructured":"Y. Igari, Y. Sugiyama, Y. Sawada, T. Iga, and M. Hanano. Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model.J. Pharmacokin. Biopharm. 11: 577\u2013593 (1983).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"BF01059331_CR35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF01061478","volume":"13","author":"H. Harashima","year":"1985","unstructured":"H. Harashima, Y. Sawada, Y. Sugiyama, T. Iga, and M. Hanano. Analysis of non-linear tissue distribution of quinidine in rats by physiologically based pharmacokinetics.J. Pharmacokin. Biopharm. 13:425\u2013440 (1985).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"BF01059331_CR36","unstructured":"T. Itoh, Y. Sawada, T. Iga, and M. Hanano. Unpublished data."},{"key":"BF01059331_CR37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF01059183","volume":"10","author":"Y. Igari","year":"1982","unstructured":"Y. Igari, Y. Sugiyama, S. Awazu, and M. Hanano. Comparative physiologically based pharmacokinetics of hexobartital, phenobarbital and thiopental in the rat.J. Pharmacokin. Biopharm. 10:53\u201375 (1982).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"BF01059331_CR38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00614387","volume":"7","author":"I. Odar-Cederloff","year":"1974","unstructured":"I. Odar-Cederloff and O. Borga. Kinetics of diphenylhydantoin in uremic patients: Consequences of decreased plasma protein binding.Eur. J. Clin. Pharmacol. 7:31\u201337 (1974).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BF01059331_CR39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/cpt1974162355","volume":"16","author":"D. Kurata","year":"1974","unstructured":"D. Kurata and G. R. Wilkinson. Erythrocyte uptake and plasma binding of diphenylhydantoin.Clin. Pharmacol. Ther. 16:355\u2013362 (1974).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF01059331_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01066591","volume":"3","author":"D. D. Breimer","year":"1975","unstructured":"D. D. Breimer, C. Honhoff, W. Zilly, E. Richter, and J. M. van Rossum. Pharmacokinetics of hexobarbital in man after intravenous infusion.J. Pharmacokin. Biopharm. 3:1\u201311 (1975).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"BF01059331_CR41","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/cpt1978235525","volume":"23","author":"W. Zilly","year":"1978","unstructured":"W. Zilly, D. D. Breimer, and E. Richter. Hexobarbital disposition in compensated and recompensated cirrhosis of the liver.Clin. Pharmacol. Ther. 23:525\u2013534 (1978).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF01059331_CR42","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1248\/cpb.21.2749","volume":"21","author":"Y. J. Lin","year":"1973","unstructured":"Y. J. Lin, S. Awazu, M. Hanano, and H. Nogami. Pharmacokinetic aspects of elimination from plasma and distribution to brain and liver of barbiturates in rat.Chem. Pharm. Bull. (Tokyo) 21:2749\u20132756 (1973).","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"BF01059331_CR43","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/jps.2600630717","volume":"63","author":"M. Ernebo","year":"1974","unstructured":"M. Ernebo. Pharmacokinetics and distribution properties of pentobarbital in humans following oral and intravenous administration.J. Pharm. Sci. 63:1114\u20131118 (1974).","journal-title":"J. Pharm. Sci."},{"key":"BF01059331_CR44","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF00562320","volume":"8","author":"M. Ehrnebo","year":"1975","unstructured":"M. Ehrnebo and I. Oder-Cederlof. Binding of amobarbital, pentobarbital and diphenylhydantoin to blood and plasma proteins in healthy volunteers and uraemic patients.Eur. J. Clin. Pharmacol. 8:445\u2013453 (1975).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BF01059331_CR45","first-page":"752","volume":"225","author":"S. Toon","year":"1983","unstructured":"S. Toon and M. Rowland. Structure-pharmacokinetic relationships among the barbiturates in the rat.J. Pharmacol. Exp. Ther. 225:752\u2013763 (1983).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF01059331_CR46","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/jps.2600610936","volume":"61","author":"H. B. Hucker","year":"1972","unstructured":"H. B. Hucker. Effect of halofenate on binding of various drugs to human plasma protein and on the plasma half life of antipyrine in monkeys.J. Pharm. Sci. 61:1490\u20131492 (1972).","journal-title":"J. Pharm. Sci."},{"key":"BF01059331_CR47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cpt197925151","volume":"25","author":"J. T. Slattery","year":"1979","unstructured":"J. T. Slattery, G. Levy, A. Jain, and F. G. McMahon. Effect of naproxen on the kinetics of elimination and anticoagulant activity of a single dose of warfarin.Clin. Pharmacol. Ther. 25:51\u201366 (1979).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF01059331_CR48","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/cpt19741661052","volume":"16","author":"S. B. Matin","year":"1974","unstructured":"S. B. Matin, S. H. Wan, and J. H. Karam. Pharmacokinetics of tolbutamide: Prediction by concentration in saliva.Clin. Pharmacol. Ther. 16:1052\u20131057 (1974).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF01059331_CR49","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1016\/0006-2952(81)90611-0","volume":"30","author":"O. Sugita","year":"1981","unstructured":"O. Sugita, Y. Sawada, Y. Sugiyama, T. Iga, and M. Hanano. Prediction of drug-drug interaction fromin vitro plasma protein binding and metabolism: A study of tolbutamidesulfonamide interaction in rats.Biochem. Pharmacol. 30:3347\u20133354 (1981).","journal-title":"Biochem. Pharmacol."},{"key":"BF01059331_CR50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00606683","volume":"13","author":"U. Klotz","year":"1978","unstructured":"U. Klotz, T. Rapp, and W. A. Muller. Disposition of valproic acid in patients with liver disease.Eur. J. Clin. Pharmacol. 13:55\u201360 (1978).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BF01059331_CR51","first-page":"255","volume":"204","author":"W. Loscher","year":"1978","unstructured":"W. Loscher. Serum protein binding and pharmacokinetics of valproate in man, dog, rat and mouse.J. Pharmacol. Exp. Ther. 204:255\u2013261 (1978).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF01059331_CR52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF01061382","volume":"23","author":"A. J. Wilensky","year":"1982","unstructured":"A. J. Wilensky, P. N. Friel, R. H. Levy, C. P. Comfort and S. P. Kaluzny. Kinetics of phenobarbital in normal subjects and epileptic patients.Eur. J. Clin. Pharmacol. 23:87\u201392 (1982).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BF01059331_CR53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/clpt.1980.72","volume":"27","author":"I. M. Patel","year":"1980","unstructured":"I. M. Patel, R. H. Levy, and R. E. Cutler. Phenobarbital-valproic acid interaction.Clin. Pharmacol. Ther. 27:32\u201336 (1980).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF01059331_CR54","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.2042-7158.1971.tb12777.x","volume":"23","author":"J. N. Mcarther","year":"1971","unstructured":"J. N. Mcarther, P. D. Dawkins, and M. J. H. Smith. The binding of indomethacin, salicylate and phenobarbital to human whole bloodin vitro.J. Pharm. Pharmacol. 23:32\u201336 (1971).","journal-title":"J. Pharm. Pharmacol."},{"key":"BF01059331_CR55","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1476-5381.1972.tb07292.x","volume":"44","author":"G. E. Mawer","year":"1972","unstructured":"G. E. Mawer, N. E. Miller, and L. A. Turnberg. Metabolism of amylobarbitone in patients with chronic liver disease.Br. J. Pharmacol. 44:549\u2013560 (1972).","journal-title":"Br. J. Pharmacol."},{"key":"BF01059331_CR56","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1476-5381.1970.tb10364.x","volume":"39","author":"K. Balasubramaniam","year":"1970","unstructured":"K. Balasubramaniam, S. B. Lucas, G. E. Mawer, and P. J. Simons. The kinetics of amylobarbitone metabolism in healthy men and women.Br. J. Pharmacol. 39:564\u2013572 (1970).","journal-title":"Br. J. Pharmacol."},{"key":"BF01059331_CR57","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000136870","volume":"17","author":"H. R. Oches","year":"1978","unstructured":"H. R. Oches, D. J. Greenblatt, E. Woo, K. Franke, and T. W. Smith. Effect of propranolol on pharmacokinetics and acute electrocardiographic changes following intravenous quinidine in humans.Pharmacology 17:301\u2013306 (1978).","journal-title":"Pharmacology"},{"key":"BF01059331_CR58","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2125.1975.tb00570.x","volume":"3","author":"I. E. Hughes","year":"1975","unstructured":"I. E. Hughes, K. E. Ilett, and I. B. Jellett. The distribution of quinidine in human blood.Br. J. Clin. Pharmacol. 3:521\u2013525 (1975).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BF01059331_CR59","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.2042-7158.1972.tb08889.x","volume":"24","author":"S. H. Curry","year":"1972","unstructured":"S. H. Curry. Relation between binding to plasma protein, apparent volume of distribution and rate constants of disposition and elimination for chlorpromazine in three species.J. Pharm. Pharmacol. 24:818\u2013819 (1972).","journal-title":"J. Pharm. Pharmacol."},{"key":"BF01059331_CR60","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.2042-7158.1975.tb09392.x","volume":"27","author":"M. H. Bickel","year":"1975","unstructured":"M. H. Bickel. Binding of chlorpromazine and imipramine to red cells, albumin, lipoproteins and other blood components.J. Pharm. Pharmacol. 27:733\u2013738 (1975).","journal-title":"J. Pharm. Pharmacol."},{"key":"BF01059331_CR61","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/cpt1974163part1424","volume":"16","author":"M. Ehrnebo","year":"1974","unstructured":"M. Ehrnebo, S. Agurell, L. O. Boreus, E. Gordon, and U. Lonroth. Pentazocine binding to blood cells and plasma proteins.Clin. Pharmacol. Ther. 16:424\u2013429 (1974).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF01059331_CR62","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0016-5085(79)80017-7","volume":"77","author":"E. A. Neal","year":"1979","unstructured":"E. A. Neal, P. J. Meffin, P. B. Gregory, and T. F. Blaschke. Enhanced bioavailabilty and decreased clearance of analgesics in patients with cirrhosis.Gastroenterology 77:96\u2013102 (1979).","journal-title":"Gastroenterology"},{"key":"BF01059331_CR63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.2042-7158.1974.tb12811.x","volume":"26","author":"S. Agurell","year":"1974","unstructured":"S. Agurell, L. O. Boreus, E. Gordon, J. E. Lindgrem, M. Ehrnebo, and U. Lonroth. Plasma and cerebrospinal fluid concentrations of pentazocine in patients: Assay by mass fragmentography.J. Pharm. Pharmacol. 26:1\u20138 (1974).","journal-title":"J. Pharm. Pharmacol."},{"key":"BF01059331_CR64","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/cpt1977226888","volume":"22","author":"M. Ehrnebo","year":"1977","unstructured":"M. Ehrnebo, L. O. Boreus, and U. Lonroth. Bioavailability and first-pass metabolism of oral pentazocine in man.Clin. Pharmacol. Ther. 22:888\u2013892 (1977).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF01059331_CR65","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/jps.2600730631","volume":"73","author":"Y. Igari","year":"1984","unstructured":"Y. Igari, Y. Sugiyama, Y. Sawada, T. Iga, and M. Hanano.In vitro andin vivo assessment of hepatic and extrahepatic metabolism of diazepam in the rat.J. Pharm. Sci. 73:825\u2013828 (1984).","journal-title":"J. Pharm. Sci."},{"key":"BF01059331_CR66","volume-title":"SALS, A Computer Program for Statistical Analysis with Least Squares Fitting","author":"T. Nakagawa","year":"1978","unstructured":"T. Nakagawa, Y. Koyanagi, and H. Togawa. SALS, A Computer Program for Statistical Analysis with Least Squares Fitting. Library Program of University of Tokyo Computer Center, Tokyo, Japan (1978)."},{"key":"BF01059331_CR67","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00616415","volume":"8","author":"E. J. Triggs","year":"1975","unstructured":"E. J. Triggs, R. L. Nation, A. Long, and J. J. Ashley. Pharmacokinetics in the elderly.Eur. J. Clin. Pharmacol. 8:55\u201362 (1975).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BF01059331_CR68","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF00566533","volume":"11","author":"J. Aarbakke","year":"1977","unstructured":"J. Aarbakke, O. M. Bakke, E. J. Milde, and D. S. Davies. Disposition and oxidation metabolism of phenylbutazone in man.Eur. J. Clin. Pharmacol. 11:359\u2013366 (1977).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BF01059331_CR69","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF00645134","volume":"12","author":"D. Horwitz","year":"1977","unstructured":"D. Horwitz, S. S. Thorgeirsson, and J. R. Mitchell. The influence of allopurinol and size of dose on the metabolism of phenylbutazone in patients with gout.Eur. J. Clin. Pharamcol. 12:133\u2013136 (1977).","journal-title":"Eur. J. Clin. Pharamcol."},{"key":"BF01059331_CR70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00561677","volume":"17","author":"P. J. Neuvonen","year":"1980","unstructured":"P. J. Neuvonen and E. E. Elonen. Effect of activated charcoal on absorption and elimination of phenobarbital, carbamazepine and phenylbutazone in man.Eur. J. Clin. Pharmacol. 17:51\u201357 (1980).","journal-title":"Eur. J. Clin. Pharmacol."}],"container-title":["Journal of Pharmacokinetics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01059331.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01059331\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01059331","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T13:14:44Z","timestamp":1586092484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01059331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,10]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1985,10]]}},"alternative-id":["BF01059331"],"URL":"https:\/\/doi.org\/10.1007\/bf01059331","relation":{},"ISSN":["0090-466X"],"issn-type":[{"value":"0090-466X","type":"print"}],"subject":[],"published":{"date-parts":[[1985,10]]}}}